2-Pyrrolylethylamine
 | |
| Clinical data | |
|---|---|
| Other names | 2-(2-Pyrrolyl)ethylamine; NEA; 2-NEA |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C6H10N2 |
| Molar mass | 110.160 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-Pyrrolylethylamine (NEA, 2-NEA, or 2-(2-pyrrolyl)ethylamine) is a chemical compound of the arylalkylamine family.[1]
It is related to other arylalkylamines as well as trace amines including tryptamine (2-indolylethylamine), phenethylamine (2-phenylethylamine), 2-furylethylamine, thiopropamine (1-(2-thienyl)-2-aminopropane), and isocyclamine (cyclopentanylaminopropane), among others.[1] Many of these compounds are monoamine releasing agents and/or reuptake inhibitors.[1]
NEA is known to be pharmacologically active itself, for instance having histamine-like activity on the isolated guinea pig ileum and having effects on gastric acid secretion in dogs.[1]
The compound was first described in the scientific literature by 1949.[1]
See also
[edit]References
[edit]- ^ a b c d e Shulgin A, Manning T, Daley PF (2011). "#67. FEA". The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press. pp. 138–141. ISBN 978-0-9630096-3-0. OCLC 709667010.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |